ClinicalTrials.Veeva

Menu

Comparison of Transversalis Fascia Plane Block and Erector Spinae Plane Blocks in Cesarean Section

E

Erzurum Regional Training & Research Hospital

Status

Unknown

Conditions

Postoperative Pain
Pain

Treatments

Drug: Bupivacaine 0.25% Injectable Solution

Study type

Interventional

Funder types

Other

Identifiers

NCT05117307
TFP vs ESP on C/S

Details and patient eligibility

About

Cesarean section is one of the most common major surgical procedures performed worldwide,, Post-cesarean analgesia should provide adequate pain control while allowing the mother to remain active to meet the needs of the baby. Insufficient analgesia after cesarean section may be associated with acute postoperative pain, chronic pain, higher opioid consumption, delayed functional capacity, and postpartum depression. Techniques such as neuraxial techniques, oral and intravenous agents, wound infiltration, and behavioral therapy can be used in the treatment of post-cesarean pain pain. In addition, Transversus abdominis plane block (TAP), Quadratus Lumborum block (QLB), Erector Spina block (ESP), Transversalis Fascia plane block (TFP) are used safely under ultrasound guidance. In this study, it was aimed primarily to examine the effects of TFP and ESP blocks on pain scores, and secondarily to evaluate analgesic consumption.

Enrollment

60 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Between 18-50 years
  • Cesarean Section

Exclusion criteria

  • Cesarean Section under general anesthesia
  • emergency cases
  • those with a body mass index greater than 35 kg/m2
  • coagulopathy
  • local infection

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

60 participants in 2 patient groups

Group ESP
Active Comparator group
Description:
Ultrasound-guided erector spinae plane block with 20 ml %0.25 bupivacaine, per side
Treatment:
Drug: Bupivacaine 0.25% Injectable Solution
Group TFP
Active Comparator group
Description:
Ultrasound-guided Transversalis Fascia Plane Block block with 20 ml %0.25 bupivacaine, per side
Treatment:
Drug: Bupivacaine 0.25% Injectable Solution

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems